Repligen (RGEN) Restructuring Costs (2012 - 2026)
Repligen (RGEN) reported Restructuring Costs of $1.5 million for Q1 2026, down 24.18% year-over-year from $2.0 million in Q1 2025, and down 24.18% quarter-over-quarter from $2.0 million in Q1 2025.
Repligen (RGEN) Restructuring Costs (2012 - 2026) Analysis & Trends
Repligen (RGEN) has 5 years of Restructuring Costs data on file, last reported at $1.5 million in Q1 2026.
- Restructuring Costs for Q1 2026 came in at $1.5 million, down 24.18% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.4 million (up 37.46% YoY), and the FY2014 annual result was $1.9 million, up 2032.89% from the prior year.
- Restructuring Costs retreated to $1.5 million in Q1 2026 per RGEN's latest filing, from $2.0 million in the prior quarter.
- Over five years, Restructuring Costs peaked at $2.0 million in Q1 2025 and troughed at $1.5 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Repligen | 7.41 Bn | 6.42 Bn | 108.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.50 Mn |
| Mar 31, 2025 | 1.97 Mn |
| Dec 31, 2014 | 1.95 Mn |
| Sep 30, 2014 | 10,000.00 |
| Jun 30, 2014 | 18,000.00 |
| Mar 31, 2014 | 98,000.00 |
| Dec 31, 2013 | 45,000.00 |
| Sep 30, 2013 | 65,000.00 |
| Jun 30, 2013 | 35,000.00 |
| Mar 31, 2013 | -54,000.00 |
| Dec 31, 2012 | 267,000.00 |
| Sep 30, 2012 | 344,000.00 |